Background/Aims: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. However, the molecular mechanisms responsible for its tumorigenesis and progression remain largely unknown. Circular RNA (circRNA) is a novel type of noncoding RNA that can serve as an ideal biomarker due to its stability. Recent evidence suggests that circRNAs play important roles in tumorigenesis. This study aims to investigate circRNA expression profiles and their potential biological functions in PTC. Methods: High-throughput RNA sequencing was used to assess circRNA expression profiles in PTC, and quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate dysregulated circRNAs. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic value of circRNAs for PTC. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were employed to determine the biological functions of differentially expressed circRNAs. Bioinformatic analyses were applied to predict interactions between circRNAs and microRNAs (miRNAs), and a circRNA-miRNA-mRNA network was constructed using Cytoscape software. Results: We identified a number of differentially expressed circRNAs in PTC tissues compared with paired normal thyroid tissues, with chr5:160757890-160763776−, chr12:40696591-40697936+, chr7:22330794-22357656−, and chr21:16386665-16415895− being upregulated, and chr7:91924203-91957214+, chr2:179514891-179516047−, chr9:16435553-16437522−, and chr22:36006931-36007153− being downregulated. These findings were confirmed by qRT-PCR, and ROC curves indicated that they can serve as potential biomarkers for PTC. GO and KEGG pathway analyses showed that some of these circRNAs are related to cancers. Additionally, bioinformatic analyses revealed a potential competingendogenous-RNA-regulating network among circRNAs, miRNAs, and mRNAs. Conclusions:
Introduction
The incidence of thyroid cancer has increased rapidly (>5% per year in both men and women) over the past several decades [1] . Accounting for more than 80% of all cases, papillary thyroid carcinoma (PTC) represents the major histopathologic type of thyroid cancer [2] . Although PTC is usually curable, with a 5-year survival of over 95%, PTCs with more aggressive phenotypes, such as extrathyroidal extension, multifocal tumors, and lymph node and distant metastases, can dedifferentiate into more lethal thyroid cancers. These more aggressive PTCs may not be efficiently managed by traditional treatments, such as surgery, thyroid hormone therapy, or radioactive iodine therapy [3] . Therefore, it is necessary to identify individuals with a genetic predisposition toward PTC and those with potentially more aggressive types of PTC who may need individual treatment strategies or novel therapeutic approaches.
Some genetic alterations associated with PTC pathogenesis (e.g., BRAF, RAS, and RET/ PTC mutations) have been evaluated as diagnostic or prognostic markers [2, 3] , though the molecular markers reported thus far are mainly protein-coding genes. However, it is estimated that less than 2% of the human genome encodes proteins, and the majority of the human transcriptome consists of noncoding RNAs. Accumulating evidence demonstrates that noncoding RNAs, such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), play an important regulatory role in many physiological and pathophysiological processes. More recently, a novel class of noncoding RNA termed circular RNA (circRNA) has become a hot topic in RNA research. In contrast to linear RNAs that are terminated with 5′ caps and 3′ tails, circRNAs are characterized by covalently closed continuous loops with neither 5′-3′ polarity nor a polyadenylated tail [4] . circRNAs are commonly found in mammalian cells and can regulate gene expression at the transcriptional or post-transcriptional level by acting as miRNA sponges or by interacting with other molecules [5] . Although circRNAs were discovered decades ago, studies about their functions have emerged only recently. Moreover, circRNAs appear to be expressed in tissue-and developmental-stage-specific manners, which indicates that they function in many physiological and pathophysiological processes [6, 7] . Similar to miRNAs and lncRNAs, researchers have also found that circRNAs are related to many diseases, such as atherosclerosis, nervous system disorders, and a variety of cancers [8] [9] [10] [11] . circRNAs are stable in cells because they are resistant to exonucleases; thus, circRNAs may constitute ideal biomarkers for cancer diagnosis [12] . Regardless, identifying dysregulated circRNAs in different cancers and elucidating their functions remains an ongoing process in cancer research.
To date, little is known about the associations between circRNAs and PTC. Therefore, in the current study, we screened the circRNA profiles of PTC patients using high-throughput RNA sequencing (RNA-Seq) and validated dysregulated circRNAs in PTC tissues by quantitative real-time polymerase chain reaction (qRT-PCR). Bioinformatic analysis was then performed to predict their potential roles in PTC and lay a foundation for future studies of circRNAs that are related to PTC.
Materials and Methods

Patient samples
A total of 90 pairs of PTC and adjacent normal thyroid tissues were collected from patients at the Department of Head and Neck Surgery of the Zhejiang Cancer Hospital between September 2016 and August 2017 (Tables 1 and 2 ). The diagnosis of PTC and the adjacent normal tissues was independently RNA extraction and quality control Total RNA was isolated from each tissue sample using TRIzol reagent (Life Technologies, Carlsbad, CA, USA) following the manufacturer's instructions. The quality of the RNA samples was determined by OD 260/280 assessment using a NanoDrop ND-2000 instrument (Thermo Fisher Scientific, Waltham, MA, USA). RNA integrity was determined by denaturing agarose gel electrophoresis.
circRNA sequencing and bioinformatic analysis Total RNA from each sample was used to prepare circRNA sequencing libraries according to a previously described protocol [13] . Paired-end reads were harvested from an Illumina HiSeq 4000 sequencer, and quality control was performed with a Q30. After 3′ adapter trimming and low-quality read removal with cutadapt software (v1.9.3), high-quality reads were aligned to the reference genome/transcriptome with STAR software [14] . circRNAs were detected and annotated with DCC software [15] using two public circRNA databases: circBase [16] and circ2Traits [17] . The junction read counts were normalized, and differentially expressed circRNAs were determined using the edgeR package of R software [18] . circRNAs that exhibited fold changes (FCs) ≥ 2.0 with P values < 0.05 were considered to be significantly differentially expressed. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for the host genes of the differentially expressed circRNAs. circRNA-miRNA interactions and miRNA targets were predicted with popular target prediction software [19, 20] , and a network was constructed with Cytoscape software [21] . 
qRT-PCR validation
Qualified total RNA was reverse transcribed to synthesize cDNA using PrimeScript RT Master Mix (Perfect Real Time, TaKaRa, Shiga, Japan) and then analyzed by qRT-PCR with SYBR Premix Ex Taq II (Tli RHaseH Plus, TaKaRa) and a LightCycler 480 system (Roche, Basel, Switzerland). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the internal control. The primers used for qRT-PCR analysis were as follows: chr5:160757890-160763776− (F 5′-TGGGGTGCTTTGTCTTCGTT-3′, R 5′-TCAGTTGTGTATCCATCTTGTTGAC-3′), chr12:40696591-40697936+ (F 5′-ACTGAAAGAGCTGCTATGCCT-3′, R 5′-AAGACCGCAAGTGTGGAAGA-3′), chr7:22330794-22357656− (F 5′-TGCCTCTCATTCCTGCCAGA-3′, R 5′-TCTTGATAGAGTCGCAGATGTTAGA-3′), chr21:16386665-16415895− (F 5′-TCTGAAGACTCCGGATGACA-3′, R 5′-GTGTGCATCTTCTGGCTGTG-3′), chr7:91924203-91957214+ (F 5′-TCGAGCTCATGAATGTGAAAGATG-3′, R 5′-GTGCTTTACGGAATTTGGTGGT-3′), chr2:179514891-179516047− (F 5′-AAGCCAGTTCCTGTTGCAGA-3′, R 5′-TTTGCTGGTGGGACTTCTGG-3′), chr9:16435553-16437522− (F 5′-CGAAGCCGAGACAGGATGC-3′, R 5′-GCCTGCCCTTCTTTCTCCTG-3′), chr22:36006931-36007153− (F 5′-TACCTGGAGGCTCTTTAAGGGT-3′, R 5′-CAGACGCCTTCATCTCGTCC-3′) and GAPDH (F 5′-CAGGAGGCATTGCTGATGAT-3′, R 5′-GAAGGCTGGGGCTCATTT-3′). The relative expression level of each circRNA was calculated using the 2 −∆∆Ct method.
Statistical analyses
Statistical analyses were performed using Prism 6 (GraphPad Software, La Jolla, CA) and SPSS 19.0 (IBM, Chicago, IL, USA). P < 0.05 was considered statistically significant. Differences between groups were assessed using Student's t test or Wilcoxon's rank-sum test, as appropriate. Receiver operating characteristic (ROC) curves were established to evaluate the diagnostic value of circRNAs for PTC.
Results
Overview of circRNA profiles
A total of 9, 103 circRNAs were identified by RNA-Seq in three pairs of PTC and normal thyroid tissue samples. Statistically significant differentially expressed circRNAs between the two groups are displayed through FC filtering ( Fig. 2A, B) . The heat map 2D , the transcription of differentially regulated circRNAs was found to be widely distributed among all chromosomes except chr13 and chr20, with chr2, chr7, chr12, chr1, and chr8 being the top five. Among these differentially expressed circRNAs, 70 are exonic and seven intronic; one belongs to the group of intergenic circRNAs, and nine are transcribed from overlapping areas (Fig. 2E) . Moreover, 33 were identified as new circRNAs that have not been annotated in the circBase or circ2Traits database. The top 20 up-and downregulated circRNAs are listed in Table  3 according to FC.
Validation of circRNA expression
Eight circRNAs (four were the most differentially expressed, and four were randomly chosen) were selected to verify the RNA-Seq in another 44 pairs of samples by qRT-PCR. The results revealed that expression of chr5:160757890-160763776−, chr12:40696591-40697936+, chr7:22330794-22357656−, and chr21:16386665-16415895− was upregulated, whereas that of chr7:91924203-91957214+, chr2:179514891-179516047−, chr9:16435553-16437522−, and chr22:36006931-36007153− was downregulated (Fig.  3A) . The qRT-PCR data were strongly consistent with the circRNA sequencing data (Fig. 3B) , indicating the reliability of the RNA-Seq results.
Diagnostic value of qRT-PCR-validated circRNAs
To assess whether the identified circRNAs can serve as potential diagnostic biomarkers for PTC, we built ROC curves for qRT-PCR-validated circRNAs using both a discovery cohort (n = 44, Fig. 4A) and a validation cohort (n = 43, Fig. 4B ). The results revealed that these (Table 4) .
GO analysis and pathway analysis of circRNA genes GO annotation revealed the host genes of the identified differentially expressed circRNAs, as presented in Fig. 5 . The most significantly enriched GO terms in the biological process, cellular component, and molecular function categories were muscle system process (GO: 0003012, P = 1.42E-05), Z disc (GO: 0030018, P = 1.33E-07), and alpha-actinin binding (GO: 0051393, P = 1.11E-06), respectively. The results of KEGG pathway analysis of the circRNA genes are presented in Fig. 6 . The differentially expressed circRNA genes are mainly associated with autoimmune thyroid disease, viral myocarditis, allograft rejection, graft-versus-host disease, type I diabetes mellitus, epithelial cell signaling in Helicobacter pylori infection, PPAR signaling pathway, adherens junction, axon guidance, antigen processing and presentation, and herpes simplex infection.
miRNA prediction and circRNAmiRNA-mRNA network construction Because circRNAs contain corresponding miRNA binding sites and can function as miRNA sponges, to evaluate their potential functions in PTC, we investigated miRNAs potentially associated with the identified differentially expressed circRNAs using miRNA target prediction software. The first five predicted miRNAs for the top three up-and downregulated circRNAs are listed in Table 5 . For example, circRNA chr5:160757890-160763776− is predicted to harbor hsa-miR-3154, hsamiR-2392, hsa-miR-6833-5p, hsa-miR-7114-5p, and hsa-miR-5004-5p, with different seed sequence matching types (i.e., 7mer-m8, 8mer, 6mer, or imperfect; Fig. 7 ). Additionally, a circRNA-miRNA- 
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targeted mRNA network was also constructed (Fig. 8) , in which each circRNA has five associated miRNAs and every miRNA has 10 predicted mRNA targets. The network indicates the potential competing endogenous RNA (ceRNA) relationships among circRNAs, miRNAs, and mRNAs in PTC. 
Discussion
circRNAs were originally thought to be by-products of mRNA splicing errors [22] . However, recent studies have indicated that circRNAs are a stable, diverse, and conserved class of RNA molecules [7] . Compared with mRNAs, miRNAs, and lncRNAs, circRNAs are promising diagnostic and prognostic biomarkers because of their stability [23] . Owing to the advent of high-throughput RNA-Seq, numerous circRNAs have been identified as being dysregulated in certain cancers, such as gastric cancer [24] , breast cancer [25] , hepatocellular carcinoma [6, 26] , pancreatic carcinoma [27] , and esophageal carcinoma [28] ; however, their expression statuses and roles in PTC remain to be determined. In this study, we used circRNA sequencing to obtain circRNA expression profiles for PTC tissues and paired adjacent normal tissues. Consequently, we identified 87 significantly differentially expressed circRNAs, among which chr5:160757890-160763776− was the most upregulated, and chr22:36006931-36007153− the most downregulated in PTC. Among these differentially expressed circRNAs, we chose eight for qRT-PCR validation, the results of which were strongly consistent with those of circRNA sequencing, confirming the reliability of RNA-Seq. ROC curves also suggested that the validated circRNAs can serve as biomarkers for diagnosing PTC. Additionally, we identified 33 novel circRNAs from the RNA-Seq data. Although much work is needed, these novel circRNAs are specifically interesting for further study because of the lack of information about them in circRNA databases.
As circRNAs have been shown to regulate the function of their host mRNAs or parent genes [29] , we attempted to explore the potential functions of circRNAs differentially expressed in PTC by analyzing their parent genes. GO and KEGG pathway analyses revealed that the parent genes are involved in certain pathways associated with cancer, such as the PPAR signaling pathway (related circRNAs and genes: chr19:4511523-4511918− and PLIN4; chr10:97154758-97170534− and SORBS1) and adherens junction (related circRNAs and genes: chr7:116339125-116340338+ and MET; chr10:97154758-97170534− and SORBS1). Previous studies have suggested that the PPAR signaling pathway contributes to thyroid cancer [30] [31] [32] , and MET is a well-known proto-oncogene associated with multiple [4, 36] , which enables them to sequester miRNAs and act as sponges of miRNA that regulate expression of target miRNAs [37, 38] . For example, the circRNA CiRS-7 contains more than 70 binding sites for miR-7 and can function as a sponge of this miRNA [5, 39] . Due to their abundance and stability, circRNAs are more effective in sponging miRNA than are other types of RNAs [40] [41] [42] [43] [44] . We also predicted the potential miRNA targets of circRNAs and constructed a circRNA-miRNA-mRNA network to explore the function of dysregulated circRNAs in PTC. The network illustrates the potential ceRNA relationships among circRNAs, miRNAs, and mRNAs. For example, chr5:160757890-160763776−, chr12:40696591-40697936+, and chr12:94562929-94580249+, as well as chr22:36006931-36007153−, chr9:16435553-16437522−, and chr2:179517185-179517463−, are the top three up-and downregulated circRNAs and possibly regulate expression of certain mRNAs by binding to their target miRNAs. Dysregulated circRNAs may participate in the pathogenesis of PTC by regulating miRNAs and their target mRNAs. Future studies should focus on these circRNAs and their related miRNAs and mRNAs.
Several limitations should be acknowledged in the present study. First, only three pairs of samples were chosen for circRNA sequencing. The sample size for RNA-Seq is relatively small and thus some selection bias may exist. Second, the prognostic value of the circRNAs was not investigated in the present study due to the relatively short-term follow-up. Therefore, future studies with large sample sizes and long-term follow-up are still needed to verify our findings.
In conclusion, our study revealed a landscape of circRNA expression profiles in PTC. Numerous circRNAs were found to be dysregulated in PTC tissues compared with adjacent normal tissues. Our RNA-Seq and qRT-PCR results were strongly consistent. Bioinformatic analysis predicted the potential functions related to these circRNAs as well as several potential circRNA-miRNA-mRNA ceRNA-regulating networks. Additionally, the findings provide potential biomarkers for PTC. Further functional and mechanistic studies of these circRNAs will improve our understanding of tumorigenesis in PTC.
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